Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: Results of the ALFA-0701 trial
Aline Renneville(Université Paris-Sud), Claude Preudhomme(Centre Hospitalier Universitaire de Lille), Christine Terré(Hôpital André Mignot), Cécile Pautas(Centre Hospitalier Universitaire Henri-Mondor), Sylvie Chevret(Saint Louis University Hospital), Emmanuel Raffoux(Inserm), Thomas Boyer(Centre Hospitalier Universitaire Amiens-Picardie), Olivier Nibourel(Inserm), Rémy Duléry(Dana-Farber Cancer Institute), Nicolas Boissel(Inserm), Meyling Cheok(Centre de Recherche Jean Pierre Aubert), Raouf Ben Abdelali(Centre National de la Recherche Scientifique), Sylvie Castaigné(Hôpital André Mignot), Jean‐Michel Cayuela(Inserm), Hervé Dombret(University of London Institute in Paris), Sandrine Hayette(Hôpital Claude Huriez), H. Farhat(Université de Versailles Saint-Quentin-en-Yvelines)
Cited by 53
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k